An Innovative Canadian Pharmaceutical Company

Revenue Projected at $160,000,000 by 2025

Sponsored
Message: Digital Investor Awareness Program-VPH

This is a great company to follow.  Glad to see they are moving forward with this digital investor awareness program. There is so much potential here IMO.  Stellar management team with a proven track record and flawless business model.  They are expected to be EBDITA positive for the new FY.  Which started in Nov 2020. Adding Redesca (LMWH) to the portfolio of Health Canada approved and proven drugs, the future never look brighter for Valeo Pharma.  This is a stellar company with huge growth potential.  I am a buyer and have been for months.

JMHO.

Share
New Message
Please login to post a reply